exosome applications > 통합검색 | BRIC

통합검색

한빛사

내가 찾은 검색어

1exosome applications

'exosome applications' 에 대한 통합검색결과 30건입니다.

한빛사30건

최신순
관련도순

3D bioprinting of engineered exosomes secreted from M2-polarized macrophages through immunomodulatory biomaterial promotes in vivo wound healing and a
- Bioact. Mater. 2024 Nov 27:45:345-362 | https://doi.org/10.1016/j.bioactmat.2024.11.026
- 2024.11
- 바이오·의료융합
Hoai-Thuong Duc Bui

강원대학교

In this study, we isolated exosomes from pasteurized bovine milk and immobilized on polydopamine (PDA)-coated hyaluronic acid (HA)-based electrospun nanofiber (mEXO@PMAT). Although milk-derived exosomes (mEXOs) have been studied in various applications, miRNA profiles of mEXOs obtained from pasteurized milk, which have higher safety from potential infectious pathogens compared to raw milk, have not been well studied.
- J. Control. Release
- 2024.11.07
Lutetium Texaphyrin-Celecoxib Conjugate as a Potential Immuno-Photodynamic Therapy Agent
- J. Am. Chem. Soc. Jul 03 2024, | https://doi.org/10.1021/jacs.4c05978
- 2024.07
- 바이오·의료융합
Large-Area Silicon Nitride Nanosieve for Enhanced Diffusion-Based Exosome Isolation
- Small Methods May 27 2024, | https://doi.org/10.1002/smtd.202301624
- 2024.05
- 바이오·의료융합
- 이유진(UNIST, KAIST)
- 채영찬(UNIST)
Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer
- Exp. Mol. Med. 05 April 2024 | https://doi.org/10.1038/s12276-024-01209-y
- 2024.04
- 생명과학
- 김유진(한국과학기술연구원)
- 공현준(University of Illinois-Urbana-Champaign)
Delivery-mediated exosomal therapeutics in ischemia-reperfusion injury: advances, mechanisms, and future directions
- Nano Converg. Apr 30 2024, 11 (1) | https://doi.org/10.1186/s40580-024-00423-8
- 2024.04
- 바이오·의료융합
Recent advances in extracellular vesicles for therapeutic cargo delivery
- Exp. Mol. Med. 01 April 2024 | https://doi.org/10.1038/s12276-024-01201-6
- 2024.04
- 의약학
Exosome Isolation Using Chitosan Oligosaccharide Lactate-1-Pyrenecarboxylic Acid Based Self-Assembled Magnetic Nanoclusters
- Adv. Healthc. Mater. Mar 02 2024, | https://doi.org/10.1002/adhm.202303782
- 2024.03
- 바이오·의료융합
- 이평세(Harvard Medical School / UC Berkeley)
Acoustic separation and concentration of exosomes for nucleotide detection: ASCENDx
- Sci. Adv. Mar 08 2024, 10 (10) eadm8597 | https://doi.org/10.1126/sciadv.adm8597
- 2024.03
- 바이오·의료융합
Haribalan Perumalsamy

한양대학교

In this study, we overcome some of the traditional approaches to analyze the toxicity of nanomaterials that are used for various biomedical applications. In particular, many approaches on toxicity assessment of AgNPs have been previously studied using in vitro or in vivo analysis. However, there has been limited study on ex vivo toxicity evaluation, notably on human primary peripheral blood mononuclear cells (hPBMCs), which could be a feasible alternative approach to study leukocytes population.
- J. Nanobiotechnol.
- 2024.03.22
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
- Exp. Mol. Med. 04 January 2024 | https://doi.org/10.1038/s12276-023-01132-8
- 2024.01
- 의약학
Synergistic vesicle?vector systems for targeted delivery
- J. Nanobiotechnol. 03 January 2024 | https://doi.org/10.1186/s12951-023-02275-6
- 2024.01
- 바이오·의료융합
Isolation of Bovine Milk Exosome Using Electrophoretic Oscillation Assisted Tangential Flow Filtration with Antifouling of Micro-ultrafiltration Membr
- ACS Appl. Mater. Interfaces 2023 May 31;15(21):26069-26080 | https://doi.org/10.1021/acsami.3c00446
- 2023.05
- 바이오·의료융합
Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy
- Nat. Mater. 2023 Mar 23 | https://doi.org/10.1038/s41563-023-01515-2
- 2023.03
- 바이오·의료융합
Recent advances in extracellular vesicle-based organic nanotherapeutic drugs for precision cancer therapy
- Coord. Chem. Rev. Volume 479, 15 March 2023, 215006 | https://doi.org/10.1016/j.ccr.2022.215006
- 2023.03
- 바이오·의료융합
Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications
- J. Control. Release 2023 Jan;353:1127-1149 | https://doi.org/10.1016/j.jconrel.2022.12.027
- 2023.01
- 바이오·의료융합
Nanomedicine for advanced cancer immunotherapy
- J. Control. Release 2022 Nov;351:1017-1037 | https://doi.org/10.1016/j.jconrel.2022.10.004
- 2022.11
- 바이오·의료융합
- 박재형(성균관대학교)
Regulation of in vivo fate of exosomes for therapeutic applications: New frontier in nanomedicines
- J. Control. Release August 2022 | https://doi.org/10.1016/j.jconrel.2022.05.058
- 2022.08
- Santosh Bashyal(계명대학교 약학대학)
- 이상길(계명대학교 약학대학, 현 중앙대학교 약학대학)
Recent progresses in exosome-based systems for targeted drug delivery to the brain
- J. Control. Release Aug 2022, 348 S0168-3659(22)00340-6 | https://doi.org/10.1016/j.jconrel.2022.06.011
- 2022.08
Anderson Tan

서울시립대학교

1. Can you please briefly summarize the paper? Transcription factor EB (TFEB), a member of the MiT/TFE family of basic helix-loop-helix leucine zipper transcription factors, is a well established central regulator of the autophagy/lysosomal-to-nucleus signaling pathway. Our group under the guidance of Prof. Jho Eek Hoon had recently published 2 significant papers about the novel roles of TFEB in CDDpress journals - Cell Death and Differentiation and Cell Death & Disease . In particular, the paper published in Cell Death & Disease , where I am the first author, was selected as ‘’CDDpress: Our Monthly Top Picks’’. Not long ago, we had also successfully published an exhaustive and comprehensive review of TFEB in Cell Death and Differentiation (IF; 15.8). In my personal humble opinion, our findings on TFEB represents a breakthrough in TFEB field as we challenged the long standing dogma of TFEB as a regulator of autophagy/lysosomal biogenesis. To commemorate the 30th anniversary of TFEB since its first discovery, we have decided to write a comprehensive review paper entitled ‘’Past, Present, and Future Perspectives of Transcription Factor EB (TFEB): Mechanisms of regulation and association with disease’’, which was successfully published in Cell Death & Differentiation . I personally feel that a comprehensive review paper that discusses the future direction of TFEB is essential as it open up new research areas. In our review article, we analyze the past, present, and future perspectives of TFEB throughout the previous 30 years and provide thorough insights. There are six sections to this extensive review paper ranging from TFEB evolution, its massive involvement in signaling pathways and diseases and TFEB role in the centrality and dynamics of lysosomes. We also discussed the recently discovered autophagy-lysosomal-independent role of TFEB and its future prospects as an appealing therapeutic target in modulating health and disease. Our revie
- Cell Death Differ.
- 2022.07.04